Editorial introductions

Abstract

Current Opinion in Cardiology was launched in 1985. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of cardiology is divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue. SECTION EDITORS Alan BravermanAlan BravermanDr Braverman is a graduate of the University of Missouri-Kansas City School of Medicine, USA. He completed a residency in internal medicine and cardiology fellowship at Brigham and Women's Hospital and Harvard Medical School, USA, and served as Chief Medical Resident. In 1991, Dr Braverman joined the faculty at Washington University School of Medicine in St. Louis, USA, where he is currently the Alumni Endowed Professor in Cardiovascular Diseases. Dr Braverman is actively involved in the education of students, house staff and fellows at Washington University and serves as a Director of the Inpatient Cardiology Firm at Barnes-Jewish Hospital, USA. He has been awarded Teacher of the Year Award by the internal medicine residents on five occasions, the Clinical Teacher of the Year Award by the Washington University Medical Students Class of 2004, and the Benico Barzilai Teaching Award by the cardiology fellows in 2016, and the Hugh McCullough Award from the American Heart Association. In 2010, Dr Braverman was bestowed the E. Grey Dimond Take Wing Award from the University of Missouri-Kansas City. He is a Clinical Cardiologist and has a particular interest in diseases of the aorta, Marfan syndrome and hereditary aneurysm conditions. He is the Director of the Marfan Syndrome Clinic at Washington University in St. Louis and serves on the Professional Advisory Board and the Board of Directors of the Marfan Foundation. He has been awarded the Antoine Marfan Award from the Marfan Foundation in 2003. Dr Braverman is actively involved in clinical research on Marfan syndrome and related aortic diseases, including genetically triggered aortopathy, aortic dissection, and bicuspid aortic valve aortopathy. Marc RuelMarc RuelDr Marc Ruel is the Michael Pitfield Professor and Chair of the Division of Cardiac Surgery at the University of Ottawa Heart Institute, Canada. His areas of predilection include minimally invasive coronary and valve surgeries, heart transplantation, as well as complex and repeat cardiac operations. He co-developed and taught in several countries minimally invasive multivessel coronary bypass grafting -now frequently performed around the world- and introduced other novel cardiac surgical techniques on the international scene. Dr Ruel established a successful regenerative medicine research program in Ottawa, which has been continuously funded by national funding agencies for over 15 years. He was the recipient of many awards, including the Medal in Surgery from the Royal College of Physicians and Surgeons of Canada, and the Queen Elizabeth II Diamond Jubilee Medal. He led numerous studies and clinical trials on the outcomes of valve and coronary surgery. Dr Ruel has authored more than 300 publications, and written textbooks on Cardiac Surgery Techniques and on Cardiac Regeneration. He is the President-Elect of the Canadian Cardiovascular Society, the Canadian Director of the Society of Thoracic Surgeons, the past-Chairman of the Council on Cardio-Vascular Surgery and Anesthesia at the American Heart Association, and the Surgery Theme Editor for the journal Circulation. Peter H. StonePeter H. StonePeter H. Stone, MD, is a Professor of Medicine at Harvard Medical School, USA, Director of the Vascular Profiling Research Group, a Co-Director of the Center for Clinical Investigation, and Senior Physician at Brigham & Women's Hospital, USA. Dr Stone's research interests are in evaluating and managing patients with acute and chronic coronary artery disease. He is using new in-vivo methodologies to identify areas where human coronary disease will progress to determine if pre-emptive therapeutic strategies may avert adverse cardiac events. He received his undergraduate degree from Princeton University, USA, and his Medical Degree from Cornell University, USA. He completed internal medicine training at the University of California, San Francisco, USA, and then did a clinical cardiology fellowship at Pacific Medical Center in San Francisco, USA. He came to the Peter Bent Brigham Hospital as a Cardiology Research Fellow and he has remained at Brigham and Women's Hospital. He is past President of the Boston Chapter of the American Heart Association, past President of the International Society for Holter and Noninvasive Electrocardiology, and is a Fellow of the American College of Cardiology and the American Heart Association.